Synairgen (SNG)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

4.57p
   
  • Change Today:
    -0.28p
  • 52 Week High: 9.80
  • 52 Week Low: 3.40
  • Currency: UK Pounds
  • Shares Issued: 202.66m
  • Volume: 290,816
  • Market Cap: £9.26m
  • RiskGrade: 510
  • Beta: 1.36

Company Description

Synairgen is a spin-off from the University of Southampton and is headed by Stephen Holgate. The leading scientist is researching asthma and other respiratory disorders and aims to develop a replacement for asthma inhalers.

IPO Details

Issue Date 26-Oct-2004 Prospectus n/a
Issue Price 130.00p Lead Broker Robert W. Baird
Market Cap £28.20m Contact Tel 020 7488 1212
Method Placing    
Sector Pharmaceuticals & Biotech    
Market Aim    
Amount Raised £10.00m    

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Synairgen Market Data

Currency UK Pounds
Share Price 4.57p
Change Today -0.28p
% Change -5.77 %
52 Week High 9.80
52 Week Low 3.40
Volume 290,816
Shares Issued 202.66m
Market Cap £9.26m
Beta 1.36
RiskGrade 510

Synairgen Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
56.25% above the market average56.25% above the market average56.25% above the market average56.25% above the market average56.25% above the market average
76.00% above the sector average76.00% above the sector average76.00% above the sector average76.00% above the sector average76.00% above the sector average
Price Trend
74.17% below the market average74.17% below the market average74.17% below the market average74.17% below the market average74.17% below the market average
34.69% below the sector average34.69% below the sector average34.69% below the sector average34.69% below the sector average34.69% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 1
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Synairgen Dividends

No dividends found

Trades for 08-Nov-2024

Time Volume / Share Price
15:33 5,800 @ 4.35p
15:25 561 @ 4.35p
15:20 167 @ 4.35p
15:19 566 @ 4.35p
15:03 22,050 @ 4.54p

Synairgen Key Personnel

CEO Richard J Marsden

Top of Page